HGH Fragment 176-191, Ipamorelin, and CJC-1295 No DAC – Research Peptides
Explore our premium-quality HGH Fragment 176-191 (5mg), Ipamorelin (5mg), and CJC-1295 No DAC (5mg) peptides, designed for research purposes only. These peptides are commonly used in scientific studies focused on growth hormone modulation, fat metabolism, and recovery processes. Please note that these products are not for human consumption.
A modified portion of the human growth hormone molecule, HGH Frag 176-191 is researched for its potential in fat loss and metabolic regulation. It targets fat cells while avoiding the effects associated with full-length HGH, making it a focus in studies on obesity and lipid metabolism.
Ipamorelin is a selective growth hormone-releasing peptide frequently studied for its role in stimulating natural growth hormone secretion. Researchers explore its potential in muscle growth, anti-aging, and metabolic health, as well as its minimal impact on cortisol and prolactin levels.
This growth hormone-releasing hormone (GHRH) analog is often investigated for its ability to boost growth hormone levels by stimulating the pituitary gland. Research focuses on its effects on muscle development, fat loss, and recovery. CJC-1295 No DAC is widely studied in conjunction with Ipamorelin for synergistic effects.
Our peptides are produced with precision for laboratory and research use. These products are not intended for human consumption and must be used in compliance with applicable regulations.